Drug Interaction Report
6 potential interactions and/or warnings found for the following 2 drugs:
- cladribine
- Tri-Sprintec (ethinyl estradiol / norgestimate)
Interactions between your drugs
ethinyl estradiol cladribine
Applies to: Tri-Sprintec (ethinyl estradiol / norgestimate), cladribine
Cladribine may reduce the blood levels and effectiveness of ethinyl estradiol, which may make it less reliable as a form of birth control. Alternative or additional methods of birth control such as condoms should be used during treatment with cladribine and for at least 4 weeks after the last dose in each treatment course to avoid unintended pregnancy. Talk to your gynecologist or other healthcare professional for help in selecting an effective method of birth control that is best for you. If you take hormone replacement for menopause, you should contact your doctor if you experience increased frequency or worsening of your symptoms such as hot flashes, vaginal dryness, or abnormal bleeding. In addition, male patients should take precautions to prevent pregnancy of their partner during treatment with cladribine and for at least 6 months after the last dose in each treatment course.
cladribine norgestimate
Applies to: cladribine, Tri-Sprintec (ethinyl estradiol / norgestimate)
Cladribine may reduce the blood levels and effectiveness of norgestimate, which may make it less reliable as a form of birth control. Alternative or additional methods of birth control such as condoms should be used during treatment with cladribine and for at least 4 weeks after the last dose in each treatment course to avoid unintended pregnancy. Talk to your gynecologist or other healthcare professional for help in selecting an effective method of birth control that is best for you. If you take hormone replacement for menopause, you should contact your doctor if you experience increased frequency or worsening of your symptoms such as hot flashes, vaginal dryness, or abnormal bleeding. In addition, male patients should take precautions to prevent pregnancy of their partner during treatment with cladribine and for at least 6 months after the last dose in each treatment course.
Drug and food interactions
cladribine food
Applies to: cladribine
Cladribine oral products can bind to other medications. This may increase your risk of experiencing side effects. To avoid or minimize the interaction, cladribine should be taken at least 3 hours before or after other medications. Talk to your doctor if you have any questions or concerns, or if you have trouble separating the dosing times. Your doctor may be able to prescribe alternatives that do not interact. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
norgestimate food
Applies to: Tri-Sprintec (ethinyl estradiol / norgestimate)
Grapefruit juice may increase the blood levels of certain medications such as norgestimate. You may want to limit your consumption of grapefruit and grapefruit juice during treatment with norgestimate. However, if you have been regularly consuming grapefruit or grapefruit juice with the medication, then it is advisable for you to talk with your doctor before changing the amounts of these products in your diet, as this may alter the effects of your medication. Contact your doctor if your condition changes or you experience increased side effects. Orange juice is not expected to interact.
ethinyl estradiol food
Applies to: Tri-Sprintec (ethinyl estradiol / norgestimate)
Information for this minor interaction is available on the professional version.
ethinyl estradiol food
Applies to: Tri-Sprintec (ethinyl estradiol / norgestimate)
Information for this minor interaction is available on the professional version.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.